Clinical Trial Update: Impact of Recombinant Humanized Type III Collagen on the Immediate and Long-term Effects of Breast Tumor Surgery [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial sponsored by Peking University People's Hospital is evaluating the impact of recombinant humanized type III collagen on immediate and l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Recombinant humanized type III collagen (recombinant humanized type III collagen)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Breast Cancer, Collagen Protein | Phase 1 | Status: RECRUITING